R.W. Brimblecombe

1.9k total citations
69 papers, 1.5k citations indexed

About

R.W. Brimblecombe is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, R.W. Brimblecombe has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Organic Chemistry and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in R.W. Brimblecombe's work include Cholinesterase and Neurodegenerative Diseases (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Mast cells and histamine (6 papers). R.W. Brimblecombe is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Mast cells and histamine (6 papers). R.W. Brimblecombe collaborates with scholars based in United Kingdom, Slovenia and United States. R.W. Brimblecombe's co-authors include W. A. M. Duncan, G. J. DURANT, C. Robin Ganellin, J. C. EMMETT, Michael E. Parsons, M. E. Parsons, G.B. Leslie, Thomas D. Inch, D. A. A. Owen and R. R. Hunt and has published in prestigious journals such as Nature, The Lancet and Gastroenterology.

In The Last Decade

R.W. Brimblecombe

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.W. Brimblecombe United Kingdom 20 522 281 235 223 199 69 1.5k
Andrea Carmine Sweden 24 611 1.2× 548 2.0× 164 0.7× 173 0.8× 342 1.7× 26 2.4k
Akira Karasawa Japan 25 857 1.6× 251 0.9× 146 0.6× 223 1.0× 183 0.9× 185 2.7k
J. W. Black United Kingdom 13 1.1k 2.2× 468 1.7× 367 1.6× 233 1.0× 169 0.8× 36 2.6k
Gabriella Coruzzi Italy 26 811 1.6× 280 1.0× 262 1.1× 473 2.1× 435 2.2× 132 2.4k
W. Krömer Germany 21 611 1.2× 481 1.7× 342 1.5× 70 0.3× 72 0.4× 72 1.4k
W. A. M. Duncan United Kingdom 11 1.3k 2.5× 500 1.8× 402 1.7× 291 1.3× 240 1.2× 23 3.0k
Satoshi Yamamoto Japan 26 1.0k 2.0× 261 0.9× 147 0.6× 404 1.8× 194 1.0× 95 2.4k
Robert N. DeHaven United States 24 902 1.7× 822 2.9× 128 0.5× 204 0.9× 254 1.3× 61 1.9k
J. M. van Rossum Netherlands 20 986 1.9× 625 2.2× 67 0.3× 148 0.7× 390 2.0× 46 2.2k
Hsien C. Cheng United States 21 530 1.0× 270 1.0× 96 0.4× 103 0.5× 111 0.6× 53 1.4k

Countries citing papers authored by R.W. Brimblecombe

Since Specialization
Citations

This map shows the geographic impact of R.W. Brimblecombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.W. Brimblecombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.W. Brimblecombe more than expected).

Fields of papers citing papers by R.W. Brimblecombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.W. Brimblecombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.W. Brimblecombe. The network helps show where R.W. Brimblecombe may publish in the future.

Co-authorship network of co-authors of R.W. Brimblecombe

This figure shows the co-authorship network connecting the top 25 collaborators of R.W. Brimblecombe. A scholar is included among the top collaborators of R.W. Brimblecombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.W. Brimblecombe. R.W. Brimblecombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolff, Kim, et al.. (2013). Driving under the influence of drugs: report from the Expert Panel on Drug Driving. 14 indexed citations
2.
Yeomans, Neville D., R.W. Brimblecombe, J. Bradley Elder, et al.. (1995). Effects of acid suppression on microbial flora of upper gut. Digestive Diseases and Sciences. 40(S2). 81S–95S. 41 indexed citations
3.
Brimblecombe, R.W.. (1990). Mesalazine: A Global Safety Evaluation. Scandinavian Journal of Gastroenterology. 25(sup172). 66–68. 30 indexed citations
4.
Hall, Callum, et al.. (1986). Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions.. Gut. 27(5). 491–498. 37 indexed citations
5.
Keighley, M R B, Denise Youngs, V Poxon, et al.. (1984). Intragastric N-nitrosation is unlikely to be responsible for gastric carcinoma developing after operations for duodenal ulcer.. Gut. 25(3). 238–245. 35 indexed citations
6.
Torsoli, A, et al.. (1980). Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamine research : European symposium, Capri, October 18-20, 1979. Elsevier eBooks. 5 indexed citations
7.
Brimblecombe, R.W., et al.. (1979). EFFECTS OF CERTAIN MUSCARINIC ANTAGONISTS ON THE ACTIONS OF ANTICHOLINESTERASES ON CAT SKELETAL MUSCLE. British Journal of Pharmacology. 65(4). 565–571. 1 indexed citations
8.
Brimblecombe, R.W., et al.. (1979). Analysis of Y-maze learning in mice using cycloheximide. General Pharmacology The Vascular System. 10(6). 489–497. 5 indexed citations
9.
Smith, Ian R., et al.. (1978). Separation and quantification of metabolites of radiolabelled histamine in brain [proceedings].. PubMed Central. 64(3). 460P–460P. 3 indexed citations
10.
Brimblecombe, R.W., W. A. M. Duncan, D. A. A. Owen, & M. E. Parsons. (1976). The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(8). 1931–4. 28 indexed citations
11.
Brimblecombe, R.W., W. A. M. Duncan, G. J. DURANT, et al.. (1975). Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist.. British Journal of Pharmacology. 53(3). 435. 34 indexed citations
12.
Brimblecombe, R.W., et al.. (1975). Proceedings: Drug effects on avoidance behavior in selected strains of rats.. British Journal of Pharmacology. 53(3). 461. 2 indexed citations
13.
Brimblecombe, R.W., et al.. (1970). Pharmacology of some acetylcholine homologues. British Journal of Pharmacology. 39(1). 40–48. 5 indexed citations
14.
Brimblecombe, R.W., et al.. (1970). The protective actions of some anticholinergic drugs in sarin poisoning. British Journal of Pharmacology. 39(4). 822–830. 27 indexed citations
15.
Brimblecombe, R.W., et al.. (1969). ACTIONS OF SOME TOXIC SUBSTANCES (PSYCHOTOMIMETICS) ON THE CENTRAL NERVOUS SYSTEM. British Medical Bulletin. 25(3). 293–298. 6 indexed citations
16.
Pinder, Roger M., et al.. (1969). 2-Amino-3-phenyl-1,1,1-trifluoropropanes. Fluorine analogs of amphetamines. Journal of Medicinal Chemistry. 12(2). 322–324. 6 indexed citations
17.
Brimblecombe, R.W., et al.. (1968). The ganglion‐stimulating effects of some amino‐acid esters. British Journal of Pharmacology. 34(2). 358–369. 11 indexed citations
18.
Brimblecombe, R.W., et al.. (1966). THE CENTRAL AND PERIPHERAL ACTIVITY OF ACETYLENIC AMINES RELATED TO OXOTREMORINE. British Journal of Pharmacology and Chemotherapy. 26(1). 56–67. 42 indexed citations
19.
Brimblecombe, R.W., et al.. (1964). SOME PHARMACOLOGICAL EFFECTS OF A SERIES OF TRYPTAMINE DERIVATIVES. British Journal of Pharmacology and Chemotherapy. 23(1). 43–54. 19 indexed citations
20.
Brimblecombe, R.W., et al.. (1955). RESPONSES OF HYPOPHYSECTOMIZED RATS TO STRESS. Journal of Endocrinology. 12(3). 205–208. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026